Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:SPARCFinancial Services
Clear all filters
Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules
negative
Moneycontrol NaNd ago

Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules

The broader Nifty Pharma index also traded lower, falling 0.47% to 24,220.10.

ABSLBANETFABSLNN50ETABSLPSEBANKIETFBSLNIFTYCIPLAGLENMARKHEALTHYIVZINNIFTYLICNETFN50MIDCAPBETAMOMENTUMNETFNEXT50BETANIFTYQLITYNPBETPHARMABEESPVTBANIETFSPARCTECHTNIDETFFinancial ServicesHealthcare
Trade Spotlight: How should you trade Torrent Power, Bajaj Auto, Hindustan Aeronautics, Sun Pharma, PFC, Aditya Birla Capital, and others on June 23?
positive
Moneycontrol NaNd ago

Trade Spotlight: How should you trade Torrent Power, Bajaj Auto, Hindustan Aeronautics, Sun Pharma, PFC, Aditya Birla Capital, and others on June 23?

The market trend remains healthy, but a sustained close above long-term moving averages is needed for further sharp upside. Below are some short-term trading ideas to consider.

ABCAPITALABFRLABGSECABLBLABRELABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEAKCAPITBAJAJ-AUTOBIRLACORPNBIRLAMONEYBSLGOLDETFBSLNIFTYBSLSENETFGCPCAPGSEC10ABSLGVPILHALHEALTHYLTGILTBEESMOCAPITALMOMENTUMNIFTYQLITYPFCSILVERSPARCTECHTORNTPOWERAutomobile and Auto ComponentsCapital Goods
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list
positive
Moneycontrol NaNd ago

Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list

Pharma stocks led the gains on benchmark Nifty 50 and the BSE Midcap index on Tuesday. Dr Reddy's, Sun Pharma and Cipla were the top 3 Nifty gainers, amid news reports that the US FDA has asked Indian firms to help address a shortage of ifosfamide injection.

ABSL10BANKABSLBANETFABSLNN50ETABSLPSEBANK10ADDBANKIETFBSEBSLNIFTYBSLSENETFGCIPLAGILT10BETAGILT5BETAGILT5YBEESGROWWMC150GSEC10IETFGSEC5IETFHDFCMID150HEALTHYLICNMID100MID150MID150BEESMID150CASEMIDCAPMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMIDSELIETFMOBANK10MOMENTUMNIFTYQLITYPHARMABEESPVTBANIETFSBINMID150SDL26BEESSPARCTECHTOP10ADDTOP15IETFTOP20Financial ServicesHealthcare
Sensex Today | Stock Market Live: Sensex jumps 230 pts, Nifty above 23,900; KPIT Tech slips 10% on softer Q1 outlook
positive
Moneycontrol NaNd ago

Sensex Today | Stock Market Live: Sensex jumps 230 pts, Nifty above 23,900; KPIT Tech slips 10% on softer Q1 outlook

Sensex Today | Stock Market LIVE Updates: Indian benchmark indices extended the opening gains and trading around 23950. Except metal, all other sectoral indices are trading in the green with auto, FMCG, media up 1-1.5%. Nifty Midcap index trade flat and Smallcap index up 0.4%. Titan Company, M&M, Eternal, Sun Pharma, Bajaj Auto were among major gainers on the Nifty, while losers were Bajaj Finserv, HDFC Life, Coal India, Tech Mahindra, Interglobe Aviation.

ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEALLETECALPHAAONETMMQ50AONETOTALAUTOBEESAUTOIETFBAJAJ-AUTOBAJAJFINSVBANKBETFBANKIETFBIKEWOBSLGOLDETFBSLNIFTYBSLSENETFGCHEMICALCOALINDIAETERNALFMCGADDFMCGIETFGILT10BETAGILT5BETAGILT5YBEESGROWWMC150GROWWMETALGROWWSC250GSEC10ABSLGSEC10IETFGSEC5IETFHDFCGROWTHHDFCLIFEHDFCLIQUIDHDFCMID150HDFCNEXT50HDFCNIF100HDFCNIFBANHDFCNIFITHDFCNIFTYHDFCPSUBKHDFCPVTBANHDFCSENSEXHDFCSML250HEALTHYHTMEDIAINDIGOKPITTECHLICNMID100LIQUID1LIQUIDBETFMETALMETALIETFMID150MID150BEESMID150CASEMIDCAPMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDM&MMNCMOCAPITALMOMENTUMMOMENTUM30MOSMALL250MPTODAYNEXT50ETFNIFTY100EWNIFTYBETFNIFTYQLITYPHARMABEESPVTBANIETFSBINMID150SILVERSMALL250SMALLADDSMALLCAPSML100CASESPARCTECHTECHMTITANZTECHAutomobile and Auto ComponentsConsumer Durables
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.

MOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities
positive
Moneycontrol NaNd ago

Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities

Choice Institutional Equities is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1640 in its research report dated July 08, 2026.

CHOICEINSENORESSPARCFinancial ServicesHealthcare
Prev
101111